Search alternatives:
significant benefits » significant effects (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant trend » significant threat (Expand Search), significant threats (Expand Search), significant burden (Expand Search)
significant benefits » significant effects (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant trend » significant threat (Expand Search), significant threats (Expand Search), significant burden (Expand Search)
-
1
-
2
-
3
-
4
-
5
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
6
-
7
-
8
-
9
The figure shows that <i>R</i><sub>0</sub> decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied.
Published 2025“…<p>The figure shows that <i>R</i><sub>0</sub> decreases significantly under control strategies, particularly at temperatures near the peak transmission range, indicating the effectiveness of control mechanisms applied.…”
-
10
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
11
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
12
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
13
Descriptive statistics of alcohol consumption in G7 countries (in litres/capita).
Published 2024Subjects: -
14
-
15
-
16
-
17
-
18
-
19
-
20
Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013.
Published 2025Subjects: